NewsBenzingaBTIGはCullinan Therapeuticsに買いを繰り返し、価格目標を40ドルに維持します。 BTIGはCullinan Therapeuticsに買いを繰り返し、価格目標を40ドルに維持します。 Benzinga 2026.09.25 09:49 (GMT+0) Open on Benzinga Other news JD Vance Warns Companies Against 'Cheap' H-1B Replacements: 'We're Not Going to Let You Lay Off American Workers' Baird Maintains Outperform on H.B. Fuller, Lowers Price Target to $65 Baird Maintains Outperform on Charles River, Raises Price Target to $334 Arvinas Q2 2026 Earnings Call Transcript Wall Street's Most Accurate Analysts Spotlight On 3 Tech Stocks Delivering High-Dividend Yields Cantor Fitzgerald Reiterates Overweight on Aurora Innovation, Maintains $12 Price Target
JD Vance Warns Companies Against 'Cheap' H-1B Replacements: 'We're Not Going to Let You Lay Off American Workers'
